Tumor gene expression in vitro and in vivo
$984,555ZIAFY2025CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications, trials & patents
Paper 38624210Paper 38135904Paper 33798439Paper 32606003Paper 31771969Paper 30635393Paper 29773874Paper 29208378Paper 29202196Paper 28402946Paper 27653561Paper 27376106Paper 27281415Paper 27013720Paper 23010077Paper 22693251Paper 21969587Paper 20228844Paper 20203268Paper 19732724Paper 19151751Paper 15057284Paper 14634209Paper 12766909Paper 12700664
Abstract
We identified a new function for mutant KRAS, namely a key role in the export of nuclear proteins into the cytoplasm. The function lies downstream from XPO1. It is attributable to a previously unknown complex between mutant KRAS and RAN-GAP, which mediates the hydrolysis of RAN-GTP to RAN-GDP, which is involved in regulating the cytoplasmic export of nuclear proteins. This function is non-canonical in that it is independent of KRAS activities generated at the plasma membrane. These finding may have translational implications, as novel drug combinations that take advantage of this new KRAS function can cooperate with RAS inhibitors.
View original record on NIH RePORTER →